Financials & Filings Show all 2022 First Quarter Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update Form 10-Q Annual Reports Title View Add Files 2020 Form 10-K 734 KB Add Files 2020 Form 10-K 734 KB Add Files 2019 Form 10-K 737.2 KB Add Files 2019 Form 10-K 737.2 KB Proxy Statements There are no SEC filings available. Form 10-K Filing date View Mar 31, 2022 View HTML 0001140361-22-012058.pdf 0001140361-22-012058.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Mar 31, 2021 View HTML 0001193125-21-101402.pdf 0001193125-21-101402.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View May 16, 2022 View HTML 0001140361-22-019248.pdf 0001140361-22-019248.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Nov 15, 2021 View HTML 0001140361-21-037756.pdf 0001140361-21-037756.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA